Skip to content

Comparison of phenobarbital and levetiracetam in febrile seizures

Comparison of phenobarbital and levetiracetam in children with febrile seizures

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20221105056406N1
Enrollment
100
Registered
2022-11-26
Start date
2022-11-16
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Febrile convulsion(F.C). Febrile convulsions

Interventions

Intervention 1: First intervention group: The intervention method is a group of children aged 6 months to 60 months who have seizures caused by fever and have indications for drug therapy. Phenobarbit

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 60 Months

Inclusion criteria

Inclusion criteria: Age 6 months to 60 months Convulsions followed by fever

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the study History of head trauma Diseases of the central nervous system Having diabetes Suffering from certain diseases Taking medicines for specific diseases

Design outcomes

Primary

MeasureTime frame
Number of seizures after receiving levetiracetam. Timepoint: 14 days after starting the drug. Method of measurement: Questionnaire and questions from the patient's mother.;The number of seizures after receiving phenobarbital. Timepoint: 14 days after starting the drug. Method of measurement: Questionnaire and questions from the patient's mother.;Intervals between seizures after receiving levetiracetam. Timepoint: 14 days after starting the drug. Method of measurement: Questionnaire and questions from the patient's mother.;Intervals between seizures after receiving phenobarbital. Timepoint: 14 days after starting the drug. Method of measurement: Questionnaire and questions from the patient's mother.;Side effects after taking levetiracetam. Timepoint: 14 days after starting the drug. Method of measurement: Questionnaire and questions from the patient's mother.;Side effects after taking phenobarbital. Timepoint: 14 days after starting the drug. Method of measurement: Questionnaire and questions from the patient's mother.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactParastoo Amiri

Sabzevar University of Medical Sciences

Amiri.Parasto@gmail.com+98 51 4401 8319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026